Insulin-like growth factor 1 (IGF-1), also called somatomedin C, is a hormone similar in molecular structure to insulin which plays an important role in childhood growth, and has effects in adults.
IGF-1 is a protein A synthetic analog of IGF-1, mecasermin, is used in children for the treatment of growth failure
IGF-1 is an important growth hormone, mediating the protein anabolic and linear growth promoting effect of pituitary GH. It has a GH independent growth stimulating effect, which with respect to cartilage cells is possibly optimised by the synergistic action with GH.
Name:IGF1 PEPTIDES for growth failure
CAS No:61912-98-9
Synonyms:IGF,IGF-I,INSULIN-LIKE GROWTH FACTOR-I HUMAN,IGFIA,Insulin-like growth factor,HUMAN LONG R3IGF-I
IGF1, IGF-I, IGF1A, IGFI, MGF, insulin like growth factor 1, IGF
Molecular Formula:C172H265N43O51
purity:99%
Volume:0.1mg ,1mg or OEM with 10vials per kit
Terms of payment:western union,T/T,Moneygram and Bitcoin
IGF-1 AND growth hormone (GH)
IGF-1 is a hormone that manages the effects of growth hormone (GH) in your body. Together, IGF-1 and GH promote normal growth of bones and tissues. GH levels in the blood fluctuate throughout the day depending on your diet and activity levels. But IGF-1 levels remain stable
What are normal IGF-1 levels in adults?
Age (years) Reference Range (ng/mL)
21-25 85-350
26-30 85-310
31 -35 70-280
36 - 40 68-220
will igf-1 make you taller?
Treatment with IGF-I stimulated linear growth independent of the degree of shortness or diagnostic category. The mean baseline height velocity (3.1 cm/year) increased to 7.4 cm/year during the first year of treatment (p < 0.0001)
igf-1 and growth hormone
Insulin-like growth factor 1 (IGF-1): a growth hormone,
is igf-1 a steroid hormone?
IGF-1 stands for “insulin-like growth factor 1.” It's an anabolic peptide hormone that has a role in stimulating growth of cells and tissues, including muscles and bone
Type 2 Diabetes Mellitus (Type 2 DM) is a metabolic disorder group with mechanisms that include hyperglycemia, insulin resistance and hyperinsulinemia. Type 2 DM has a close association with IGF-1, where the active form of the IGF-1 becomes elevated by reason of the fact that hyperinsulinemia inhibits the production of IGF-binding proteins (IGFBP) 1/IGFBP 2. The active form of IGF-1 has the ability to promote cell proliferation and inhibit apoptosis, hence becomes one of the risk factors for cancer cell growth. This was an analytical study conducted in August at the Harapan Bunda Clinic, Medan, Indonesia to determine the difference between the IGF-1 level and blood glucose level in type 2 DM patients in different age groups. Twenty subjects with Type 2 DM participated in this study and were divided based on their age into 35-50 years old or Group 1 and 51-65 year old group or Group 2. The IGF-1 levels in both groups were compared and analyzed using the T-test dependent method. Results showed that the IGF-1 and blood glucose levels were higher in Group 1 (35-50 years old) when compared to Group 2 and the difference was significant. The change in the IGF-1 level in diabetic patients cannot be determined only by the blood sugar level.